METABOLIC EXPLORER (METEX.PA)
FR0004177046 - Common Stock
We assign a fundamental rating of 2 out of 10 to METEX. METEX was compared to 67 industry peers in the Chemicals industry. Both the profitability and financial health of METEX have multiple concerns. METEX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
METEX had negative earnings in the past year.
In the past year METEX has reported a negative cash flow from operations.
METEX had negative earnings in 4 of the past 5 years.
METEX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
METEX's Return On Assets of -22.71% is on the low side compared to the rest of the industry. METEX is outperformed by 88.89% of its industry peers.
METEX's Return On Equity of -49.02% is on the low side compared to the rest of the industry. METEX is outperformed by 92.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.71% | ||
| ROE | -49.02% | ||
| ROIC | N/A |
ROA(3y)-0.39%
ROA(5y)-4.87%
ROE(3y)-8.69%
ROE(5y)-13.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
METEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
METEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, METEX has about the same amount of shares outstanding.
The number of shares outstanding for METEX has been increased compared to 5 years ago.
The debt/assets ratio for METEX is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.42, we must say that METEX is in the distress zone and has some risk of bankruptcy.
METEX's Altman-Z score of 0.42 is on the low side compared to the rest of the industry. METEX is outperformed by 87.30% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that METEX is not too dependend on debt financing.
METEX has a Debt to Equity ratio of 0.24. This is in the better half of the industry: METEX outperforms 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.42 |
ROIC/WACCN/A
WACC7.01%
2.3 Liquidity
A Current Ratio of 1.34 indicates that METEX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.34, METEX is not doing good in the industry: 79.37% of the companies in the same industry are doing better.
A Quick Ratio of 0.79 indicates that METEX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, METEX is doing worse than 82.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
METEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -144.82%.
METEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.54%.
The Revenue has been growing by 123.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-144.82%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-616.23%
Revenue 1Y (TTM)33.54%
Revenue growth 3Y765.1%
Revenue growth 5Y123.77%
Revenue growth Q2Q-26.88%
3.2 Future
The Earnings Per Share is expected to grow by 29.77% on average over the next years. This is a very strong growth
METEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.75% yearly.
EPS Next Y9.08%
EPS Next 2Y34.93%
EPS Next 3Y29.77%
EPS Next 5YN/A
Revenue Next Year-27.56%
Revenue Next 2Y7.71%
Revenue Next 3Y11.75%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for METEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for METEX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as METEX's earnings are expected to grow with 29.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.93%
EPS Next 3Y29.77%
5. Dividend
5.1 Amount
No dividends for METEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
METABOLIC EXPLORER
EPA:METEX (12/5/2023, 7:00:00 PM)
0.4135
-0.01 (-2.59%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.97M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.71% | ||
| ROE | -49.02% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.34 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-144.82%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y9.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)33.54%
Revenue growth 3Y765.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y